Aerovate Therapeutics, Inc. (AVTE) - Winst- en verliesrekening per kwartaal

Home
AVTE
Financiële Gegevens

2.68 (USD) • At close April 28, 2025

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Omzet Numbers are in millions	0	0	0	0	0	0.136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0	0	0	0.028	0.028	0.028	0.025	0.022	0.021	0.02	0.02	0.017	0.011	0.008	0.003	0.002	0.002	0	0	0	0
Brutowinst Numbers are in millions	0	0	0	-0.028	-0.028	0.108	-0.025	-0.022	-0.021	-0.02	-0.02	-0.017	-0.011	-0.008	-0.003	-0.002	-0.002	0	0	0	0
Brutowinstmarge Numbers are in millions	0	0	0	0	0	0.794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	0	1.531	10.328	21.248	20.08	17.813	16.884	16.034	13.488	12.221	10.783	8.363	7.255	5.046	3.418	4.327	2.196	3.297	1.966	1.471	1.206
Algemene en administratieve kosten Numbers are in millions	3.387	4.872	7.082	4.917	4.538	4.253	4.484	4.302	4.151	3.631	3.369	3.852	3.764	3.222	2.782	1.447	0.584	0.366	0.277	0.154	0.152
Verkoop- en marketingkosten Numbers are in millions	0	0	0	0	-0.028	-0.028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	3.387	4.872	7.082	4.917	4.51	4.225	4.484	4.302	4.151	3.631	3.369	3.852	3.764	3.222	2.782	1.447	0.584	0.366	0.277	0.154	0.152
Overige kosten Numbers are in millions	0	0	0	0	-0.003	0.001	0.001	-0.001	-0.001	-0.077	0.004	-0.006	0	0.001	0	-0.003	-0.001	-0.003	-0.064	-0.54	-0.04
Bedrijfskosten Numbers are in millions	3.387	6.403	17.41	26.165	24.59	22.038	21.368	20.336	17.639	15.852	14.152	12.215	11.019	8.268	6.2	5.774	2.78	3.663	2.243	1.625	1.358
Bedrijfsresultaat Numbers are in millions	-3.387	-6.403	-17.41	-26.165	-24.618	-22.066	-21.368	-20.336	-17.639	-15.852	-14.152	-12.215	-11.019	-8.268	-6.2	-5.774	-2.78	-3.663	-2.243	-1.625	-1.358
Bedrijfsresultaat ratio Numbers are in millions	0	0	0	0	0	-162.25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	0.869	1.028	1.173	1.39	1.432	1.709	1.805	1.311	1.119	0.855	0.564	0.224	0.109	0.048	0.016	-0.001	-0.001	-0.003	-0.064	-0.577	-0.078
Inkomen voor belasting Numbers are in millions	-2.518	-5.375	-16.237	-24.775	-23.186	-20.357	-19.563	-19.025	-16.52	-14.997	-13.588	-11.991	-10.91	-8.22	-6.184	-5.775	-2.781	-3.666	-2.307	-2.202	-1.436
Inkomen voor belasting ratio Numbers are in millions	0	0	0	0	0	-149.684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0	0.055	0	0	-0.015	0.056	-0.025	-1.312	-1.119	0.025	-0.564	-0.224	-0.109	0.003	0	-0.002	-0.001	-0.647	-2.243	-1.588	0.038
Nettowinst Numbers are in millions	-2.518	-5.43	-16.237	-24.775	-23.186	-20.413	-19.563	-19.025	-15.401	-15.022	-13.024	-11.767	-10.801	-8.223	-6.184	-5.775	-2.781	-3.666	-2.307	-2.202	-1.436
Nettowinstmarge Numbers are in millions	0	0	0	0	0	-150.096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-0.09	-0.19	-0.56	-0.86	-0.83	-0.74	-0.71	-0.76	-0.62	-0.61	-0.53	-0.48	-0.44	-0.34	-0.26	-23.76	-0.13	-15.08	-9.49	-9.06	-0.32
Verwaterde WPA Numbers are in millions	-0.09	-0.19	-0.56	-0.86	-0.83	-0.74	-0.71	-0.76	-0.62	-0.61	-0.53	-0.48	-0.44	-0.34	-0.26	-23.76	-0.13	-15.08	-9.49	-9.06	-0.32
EBITDA Numbers are in millions	-3.387	-6.395	-17.192	-26.137	-24.59	-22.038	-21.343	-20.314	-17.618	-15.832	-14.132	-12.198	-11.008	-8.26	-6.197	-5.772	-2.778	-4.309	0	0	-1.398
EBITDA ratio Numbers are in millions	0	0	0	0	0	-162.044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Aerovate Therapeutics, Inc.

NASDAQ:AVTE Add to watchlist

NASDAQ:AVTE